Agile Therapeutics (AGRX) Issued Twirla-Related U.S. Patent

June 12, 2015 7:43 AM EDT Send to a Friend
Agile Therapeutics (Nasdaq: AGRX) announced that the U.S. Patent and Trademark Office issued US Patent 9,050,358 on June 9, 2015 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login